Apex Labs CBD has developed a new product that combines CBD with intravenous (IV) therapy. According to the company its team was able to reduce the size of the CBD molecule to make it both water-soluble and small enough to pass through a sterile filter, making it safe for intravenous use. The company says that this sterile CBD solution can bring the many benefits of cannabidiol and the hemp world to IV therapy clinics across the country and complement a variety of functional or regenerative medicine offerings.
“We were incredibly excited to be able to bring this product to the market,” stated Joe Young, CEO and co-founder of Apex Labs CBD. “Not only is it the merging of two really significant markets in the wellness industry, but it also represents how much potential there is when combining the power of science with one of nature’s greatest gifts. We’re proud to offer a new way for people to experience CBD.”
While recent developments in technology led to water-soluble CBD, and more recently, nanoemulsions, Miles Terry, (CSO, co-founder) created patent-pending technology that reduced the molecule size even further down to the size of a picometer, allowing for a sterile filtration process and maximum system absorptions.
Apex Labs CBD products are sent to a third-party testing facility, California-Ag Labs, to test for potency and purity. The comprehensive test reports are published on the website and include test results for microbes, pesticides, metals, potency, mycotoxins, and residual solvents.
Pico IV is currently available for purchase online after member registration. Each sterile vial has 50ml infused with approximately 200mg of CBD, or cannabidiol, and provides 4 doses at 50mg per dose. You must be a licensed IV therapy provider to purchase.
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Annie Spratt on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!